EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Niraparib Metabolic Stability in Human Liver Microsomes Using Ultrafast UPLC‐MS/MS Technique: In Silico Screening for Structural Alerts Related to the Metabolic Lability and In Silico DEREK Toxicity

Mohamed W Attwa iD, Ali S Abdelhameed iD, Adnan A Kadi

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Mohamed W Attwa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Microsomes, Liver, Indazoles, Piperidines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Ongoing Research Funding program at King Saud University, Riyadh, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Niraparib (Zejula; NRP) is a potent, orally bioavailable poly (ADP‐ribose) polymerase inhibitor that has been approved by the US FDA. The aim of this study was to establish a specific, fast, sustainable, and dependable UPLC‐MS/MS procedure for measuring NRP in HLMs matrix, used to compute the metabolic stability of NRP. The established approach was validated using human liver microsomes (HLMs) matrix across a level range of 1–3000 ng/mL. The intraday and interday precision and accuracy rates ranged between −3.95% and 7.58%, and −2.00% and 8.79%, respectively. The MS/MS analysis was performed in a positive ESI ionization mode, whereas chromatography employed an SB‐C18 column with 1‐min run time. The StarDrop software involved P450 and DEREK modules that were employed for the evaluation of metabolic lability and NRP structural alarms, respectively. The in vitro half‐life was determined to be 33.81 min, and the intrinsic clearance of NRP was measured at 23.98 mL/min/kg. In silico assessment indicates that small structural modifications to the piperidine ring (96%) and the indazole moiety (3%) in drug design could increase the NRP metabolic stability. The assessment of in silico ADME and metabolic stability properties is necessary for progressing novel drug studies aimed at improving metabolic stability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryMicrosomes, LiverIndazolesPiperidinesPoly(ADP-ribose) Polymerase InhibitorsHumansChromatography, High Pressure LiquidReproducibility of ResultsLinear ModelsDrug StabilityComputer SimulationLimit of DetectionLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

DEREK moduleNiraparibP450 metabolic softwareStarDrop softwareUPLC‐MS/MSin vitro metabolic stability

Substanzen

IndazolesniraparibPiperidinesPoly(ADP-ribose) Polymerase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

ORCID-Profile: Mohamed W Attwa, Ali S Abdelhameed

Förderung

  • Ongoing Research Funding program at King Saud University, Riyadh, Saudi Arabia

Zitieren

APA

Attwa, M. W., Abdelhameed, A. S., & Kadi, A. A. (2025). Evaluation of Niraparib Metabolic Stability in Human Liver Microsomes Using Ultrafast UPLC‐MS/MS Technique: In Silico Screening for Structural Alerts Related to the Metabolic Lability and In Silico DEREK Toxicity. Biomedical Chromatography. https://doi.org/10.1002/bmc.70252

Vancouver

Attwa MW, Abdelhameed AS, Kadi AA. Evaluation of Niraparib Metabolic Stability in Human Liver Microsomes Using Ultrafast UPLC‐MS/MS Technique: In Silico Screening for Structural Alerts Related to the Metabolic Lability and In Silico DEREK Toxicity. Biomedical Chromatography. 2025. doi:10.1002/bmc.70252

BibTeX
@article{Attwa2025,
  author = {Attwa, Mohamed W and Abdelhameed, Ali S and Kadi, Adnan A},
  title = {Evaluation of Niraparib Metabolic Stability in Human Liver Microsomes Using Ultrafast UPLC‐MS/MS Technique: In Silico Screening for Structural Alerts Related to the Metabolic Lability and In Silico DEREK Toxicity},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70252}
}
Kostenlos starten →